review · Materials Today Bio
Silver nanoparticles (Ag NPs) play a significant role in modern medicine, with their size, shape, and surface chemistry strongly influencing their biological performance. Smaller nanoparticles (1-100 nm) can penetrate cells more easily, while different shapes such as spheres, rods, cubes, triangles, wires, and stars impact their antimicrobial activity and drug delivery efficiency. This review highlights the importance of precise control over these properties during synthesis to optimize their therapeutic potential. Green synthesis methods, including plant-based and microbial approaches, are presented as safer, more cost-effective, and environmentally friendly alternatives to conventional chemical processes. The review also discusses surface functionalization strategies such as biodegradable coatings, targeting ligands, and hybrid structures that enhance nanoparticle stability, reduce toxicity, and enable selective delivery to sites like tumors or infected tissues. As highlighted in the review, Ag NPs hold great promise in antimicrobial therapy, targeted drug delivery, diagnostics, tissue engineering, stem cell support, and cancer treatment. Emerging research also indicates potential benefits in modulating inflammation and oxidative stress in neurological and cardiovascular disorders. Despite these advances, key challenges remain, including low synthesis yields, poor reproducibility, scale-up difficulties, potential toxicity, uncertain biological mechanisms, and a lack of regulatory clarity. The review indicates the urgent need for improved synthesis control and rigorous safety evaluations to support the clinical translation of Ag NP-based technologies.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1016/j.mtbio.2025.102071
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.